Gastroesophageal Reflux Disease Market Share

Statistics for the 2023 & 2024 Gastroesophageal Reflux Disease market share, created by Mordor Intelligence™ Industry Reports. Gastroesophageal Reflux Disease share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Gastroesophageal Reflux Disease Industry

The gastroesophageal reflux disease market is fragmented in nature owing to the presence of several market players. The market players are engaged in strategic initiatives such as mergers, acquisitions, product approvals, and launches to expand their presence. Some of the market players are Pfizer, Inc., Johnson & Johnson, SRS Life Sciences, Takeda Pharmaceutical Co., Ltd., and Haleon Group of Companies.

Gastroesophageal Reflux Disease (GERD) Market Leaders

  1. Pfizer, Inc.

  2. Johnson & Johnson

  3. SRS Life Sciences

  4. Takeda Pharmaceutical Co., Ltd.

  5. Haleon Group of Companies

*Disclaimer: Major Players sorted in no particular order

Gastroesophageal Reflux Disease Market Concentration

Gastroesophageal Reflux Disease Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)